Hydrochloric Acid

Hydrochloric Acid

SCHEMBL342565

Cl.N=C(N)NN=C=S.[CaH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15994074 0.95
Hydrochloric Acid SCHEMBL7112379 0.95
Hydrochloric Acid SCHEMBL27492535 0.95
Hydrochloric Acid SCHEMBL10589248 0.95
SCHEMBL5072658 0.92
SCHEMBL28436707 0.92
Iodide SCHEMBL20603123 0.90
Iodide SCHEMBL28453451 0.90
Hydrochloric Acid SCHEMBL197403 0.90
Hydrochloric Acid SCHEMBL342564 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604162-B2 Collectin FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2013-12-10 US disclosed
US-20130150565-A1 NOVEL COLLECTIN FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2013-06-13 US disclosed
US-8410253-B2 Scavenger receptor FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2013-04-02 US disclosed
EP-1881004-B1 Novel collectin FUSO PHARMACEUTICAL IND (JP) 2012-07-25 EP disclosed
US-20120015400-A1 HCL-K1 Polypeptide Which Offers Collectin Activity ASAHIKAWA MEDICAL COLLEGE (JP) 2012-01-19 US disclosed
US-8084578-B2 Monoclonal antibody against human scavenger receptor SRCL-P1 FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2011-12-27 US disclosed
US-7985833-B2 Collectin FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2011-07-26 US disclosed
US-20100113750-A1 NOVEL SCAVENGER RECEPTOR FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2010-05-06 US disclosed
US-20100113749-A1 NOVEL SCAVENGER RECEPTOR FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2010-05-06 US disclosed
US-20090305341-A1 HCL-K1 Polypeptide Which Offers Collectin Activity FUSO PHARMACEUTICAL INDUSTRIES, LTD (JP) 2009-12-10 US disclosed
EP-1262546-B1 NOVEL SCAVENGER RECEPTORS FUSO PHARMACEUTICAL IND (JP) 2009-09-02 EP disclosed
EP-1881004-A1 Novel collectin FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2008-01-23 EP disclosed
US-20070231859-A1 Novel scavenger receptor FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2007-10-04 US disclosed
US-20070224649-A1 Novel scavenger receptor FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2007-09-27 US disclosed
US-7189809-B2 Scavenger receptors FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2007-03-13 US disclosed
EP-1283214-B1 NOVEL COLLECTINS FUSO PHARMACEUTICAL IND (JP) 2007-02-14 EP disclosed
US-20030158382-A1 Novel collectins FUSO PHARMACEUTICAL INDUSTRIES (JP) 2003-08-21 US disclosed
US-20030108904-A1 Novel scavenger receptors FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2003-06-12 US disclosed
EP-1283214-A1 NOVEL COLLECTINS FUSO PHARMACEUTICAL INDUSTRIES LTD. (JP) 2003-02-12 EP disclosed
EP-1262546-A1 NOVEL SCAVENGER RECEPTORS FUSO PHARMACEUTICAL INDUSTRIES LTD. (JP) 2002-12-04 EP disclosed